Tools & Resources
- MS Diagnosis: Where to Begin
- Fight MS Flare-Ups
- MS vs. ALS
- Celebrities With MS
- Alternative MS Therapies
- Botulinum Toxin for Muscle Pain
NewsRelated to Multiple Sclerosis
- Nanoparticles Show Potential for Treating MS
Nov. 18, 2012 -- Researchers say they've been able to use nanoparticles to stop multiple sclerosis (MS) in mice that are bred to have the disease. The particles are about 200 times smaller than the thickness of a human hair. They are made from the same material that's used to create dissolving stitc
Read Full Article - Leukemia Drug Is Highly Effective MS Treatment
Oct. 31, 2012 -- Two new trials offer proof that a leukemia drug long used to treat multiple sclerosis works better than a common treatment. When compared with the widely used drug interferon beta, the leukemia drug alemtuzumab reduced relapse rates by half, researchers say. Alemtuzumab has been use
Read Full Article - Stem Cell Transplants May Show Promise for MS
Oct. 10, 2012 -- New research suggests that stem cell transplants to treat certain brain and nervous system diseases such as multiple sclerosis may be moving closer to reality. One study found that experimental stem cell transplants are safe and possibly effective in children with a rare genetic bra
Read Full Article - Infertility Treatment May Worsen MS Symptoms
Oct. 3, 2012 -- There is growing evidence that infertility treatments raise relapse rates in women with multiple sclerosis. In a new study, 3 out of 4 women with MS had increased disease activity following assisted reproductive technology (ART) infertility treatments. The study was small, with just
Read Full Article - Experimental MS Pill Continues to Show Promise
Sept. 19, 2012 -- An experimental pill is showing promise for the treatment of multiple sclerosis. In two late-phase studies appearing in The New England Journal of Medicine, the drug BG-12 (dimethyl fumarate) reduced relapses by about half in patients with the most common form of MS. If approved by
Read Full Article - FDA Approves New Multiple Sclerosis Drug Aubagio
Sept. 13, 2012 -- The FDA has approved Aubagio (teriflunomide), a new drug for the treatment of multiple sclerosis (MS). The once-a-day tablet will be prescribed to adults with relapsing forms of the chronic, incurable disease. In a two-year study, the Aubagio reduced yearly relapses by nearly a thi
Read Full Article - Multiple Sclerosis Drugs May Not Delay Disability
July 17, 2012 -- Disease-modifying drugs have been game-changers for the treatment of multiple sclerosis. The drugs help prevent relapses, but now new research questions whether they slow progression of disability from the disease. In a study of patients with relapsing-remitting MS, published in the
Read Full Article - Stress Management May Prevent MS Brain Lesions
July 11, 2012 -- Teaching MS patients how to deal with stress can improve their quality of life -- and may also prevent or slow down formation of new brain lesions, according to a new study. Patients with multiple sclerosis who attended stress management therapy sessions for six months had fewer new
Read Full Article - Botox May Ease Multiple Sclerosis Tremors
July 3, 2012 -- Many people with multiple sclerosis (MS) will develop a tremor, and until now, there was little that could be done to minimize this shaking. Now new research shows that shots of Botox, the very same wrinkle-busting injection that helps frown lines, may ease hand and arm tremors. The
Read Full Article - New Warnings for MS Drug Gilenya After FDA Review
April 20, 2012 -- Novartis, the maker of the drug Gilenya (fingolimod), a once-daily oral capsule taken for multiple sclerosis, has added stronger warnings to labels and prescription information about the drug's possible heart risks, according to a company statement. Labels will now recommend that a
Read Full Article
Displaying 41 - 50of 221 Articles<<Prev Page12345 678910Next>>